Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST) [Yahoo! Finance]
Twist Bioscience Corporation (TWST)
Last twist bioscience corporation earnings: 2/6 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
TheFly reported on December 15, 2025, that Barclays kept its Overweight rating and boosted its price objective for Twist Bioscience Corporation (NASDAQ:TWST) from $37 to $39. The move was included in the company's more comprehensive 2026 outlook report for the life sciences and diagnostics instruments industry. According to Barclays, end markets are rebounding, the last round of estimate cutbacks has mostly passed, and the healthcare industry's most under-owned sector is still tools. Based on the company's research note given to investors, all of these factors provide a favorable setting for the tools group to exceed expectations in 2026. Furthermore, Twist Bioscience Corporation (NASDAQ:TWST) released fiscal 2026 guidance. The business anticipates total revenue to be between $425 million and $435 million, which implies an increase of between 13% and 15.5% year over year. Revenue for the DNA Synthesis and Protein Solutions Group is anticipated to reach $194 million to $199 million,
Show less
Read more
Impact Snapshot
Event Time:
TWST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TWST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corporation news events
Weekly update
A roundup of the hottest topics
TWST
News
- Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 RevenueBusiness Wire
- Twist Bioscience (TWST) Valuation Check After TD Cowen Buy Rating And Raised Outlook [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience (NASDAQ:TWST) had its price target raised by analysts at TD Cowen from $32.00 to $43.00. They now have a "buy" rating on the stock.MarketBeat
- Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Cowen Inc.MarketBeat
TWST
Earnings
- 11/14/25 - Miss
TWST
Sec Filings
- 1/15/26 - Form 4
- 1/15/26 - Form 4
- 1/13/26 - Form 4
- TWST's page on the SEC website